|
TTC37 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.168380E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.351600E-04 |
| Normal-vs-Stage2 |
4.105700E-02 |
| Normal-vs-Stage3 |
4.34919999999783E-05 |
| Normal-vs-Stage4 |
1.321140E-03 |
| Stage1-vs-Stage2 |
4.696000E-01 |
| Stage1-vs-Stage3 |
2.097800E-01 |
| Stage1-vs-Stage4 |
7.605600E-01 |
| Stage2-vs-Stage3 |
1.537970E-01 |
| Stage2-vs-Stage4 |
4.335800E-01 |
| Stage3-vs-Stage4 |
5.492000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.61019999999468E-05 |
| Normal-vs-AfricanAmerican |
2.439600E-01 |
| Normal-vs-Asian |
8.765800E-04 |
| Caucasian-vs-AfricanAmerican |
1.089600E-01 |
| Caucasian-vs-Asian |
8.630600E-01 |
| AfricanAmerican-vs-Asian |
1.232200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.75660000000444E-05 |
| Normal-vs-Female |
4.403100E-04 |
| Male-vs-Female |
1.903560E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.756040E-03 |
| Normal-vs-Age(41-60Yrs) |
1.240200E-04 |
| Normal-vs-Age(61-80Yrs) |
6.202400E-04 |
| Normal-vs-Age(81-100Yrs) |
2.689600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.284000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.286800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.983000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.193000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.159400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.040800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.293750E-01 |
| Classical-VS-Follicular |
9.490600E-01 |
| Classical-VS-Other |
1.693240E-01 |
| Classical-VS-Normal |
6.176500E-04 |
| Tall-VS-Follicular |
1.712350E-01 |
| Tall-VS-Other |
5.154600E-01 |
| Tall-VS-Normal |
2.244200E-04 |
| Follicular-VS-Other |
2.728800E-01 |
| Follicular-VS-Normal |
8.637400E-03 |
| Other-VS-Normal |
6.562600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.769400E-04 |
| Normal-vs-N1 |
4.28930000000438E-05 |
| N0-vs-N1 |
2.215200E-01 |
|
|
